{"id":452689,"date":"2021-03-08T09:03:25","date_gmt":"2021-03-08T14:03:25","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=452689"},"modified":"2021-03-08T09:03:25","modified_gmt":"2021-03-08T14:03:25","slug":"delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/","title":{"rendered":"Delcath Systems to Participate at Upcoming Virtual Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, March  08, 2021  (GLOBE NEWSWIRE) &#8212; Delcath Systems, Inc. (Nasdaq:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uZBMAi4dJNZjlQB4kAll5Xe1F7vTYy3ExCFb3S5trewTqMHObl9UOQoW0TuXqT1tDwG1ZMHt7AhtfO06kyjx_POFmuwGd7WlqfC_MDTGHv3gtwkt8ZC0vR27RrGW9xjhiq460xSzikolqKTq7br_6krrthYYSP6gYeN6UhoWasLs8uqnZboOkC2hfMmgomVcAaBnH0F5PLf3WKBDwJXaXARcUTw8lTA-MAeSyy3iucRL8A-IBF5J3fAVPrbD80h1Hc0_Xsc2zkuiusBf4nNH8PQ7YSQtMPNFPD1bAnGrhWtIJueeRalfm-QnFrd-Kw_hLiGUeMaMPIk367wPC94U-5hQNbB8pavQU454028m_8ZsLoNW88_MGb2zEL7_p5K_zr1nwlaovn2vjHi8_-bYoKPFArOmhSZKWKKoKdYrnhvcRSn08dWvXEAU5lRCl7Jele6ubh_wp5oyaqPDZn2Wg138k4ZxOgSeIDXXnuT-fwztCcqcNhujth4OG4uGnfMkLG_2yK_Sxwxj_cRhOEj1D7hcwl8JUXL7UAVDp-fyGi_4v5Q3y8aQkXp0HLY_7nfdXJlVmwownv9ljibu-i7wBw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong><u>DCTH<\/u><\/strong><\/a>), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today that management will participate at these upcoming virtual investor conferences:\u00a0<\/p>\n<ul type=\"square\">\n<li style=\"margin-top:15pt;margin-bottom:3.75pt\">HC Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021. On demand viewing begins at 7:00 am (ET)\n<ul type=\"circle\">\n<li style=\"margin-top:15pt;margin-bottom:3.75pt\">Webcast Link:\u00a0<a href=\"https:\/\/journey.ct.events\/view\/7319b60b-6a39-46ed-b3cb-7703cefc889e\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/journey.ct.events\/view\/7319b60b-6a39-46ed-b3cb-7703cefc889e<\/a><\/li>\n<\/ul>\n<\/li>\n<li style=\"margin-top:15pt;margin-bottom:3.75pt\">Virtual 33rd Annual Roth Conference March 15 \u2013 17\n<ul type=\"circle\">\n<li style=\"margin-top:15pt;margin-bottom:3.75pt\">1&#215;1 meetings only<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>For more information or to schedule a one-on-one meeting with management, please contact your conference representative or James@HaydenIR.com.<\/p>\n<p>\n        <strong>About Delcath Systems, Inc.<\/strong>\n      <\/p>\n<p>Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational product, HEPZATO KIT (melphalan hydrochloride for injection\/hepatic delivery system), is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. HEPZATO KIT has not been approved by the U.S. Food &amp; Drug Administration (FDA) for sale in the U.S. In Europe, our system is marketed under the trade name Delcath CHEMOSAT\u00ae Hepatic Delivery System for Melphalan (CHEMOSAT) and has been CE Marked and used at major medical centers to treat a wide range of cancers of the liver. CHEMOSAT is being marketed under an exclusive licensing agreement with medac GmbH, a privately held multi-national pharmaceutical company headquartered in Germany that specializes in the treatment and diagnosis of oncological, urological and autoimmune diseases.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>\n        <em>Delcath Investor Relations<\/em>\n      <\/p>\n<p>Email:\u00a0<strong><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NPN8QUWzC1m1OATfFPMxJeTwXR5CkCiGlGkQ0WT3q5baAe95Ho4L2vEp-IV1ImORh-ImVJoh1DtRS69ipELCEyq7J0m7_ho_Xon0ewn_wWoI6RndxqcrBRPKv_VAyUGE\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investorrelations@delcath.com<\/a><\/u><\/strong><\/p>\n<p>\n        <em>Hayden IR<\/em>\n      <\/p>\n<p>James Carbonara\u00a0<br \/>(646)-755-7412\u00a0<br \/><strong><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vBir3btMbHcblQH9kzPAM4vuF-G8kcmEAktAdLeNh9ZuH9lK2-YZZybZWBa20w8Rr8nB5AHDUJR0Fv0apacWkmrKQ8WLvCEl6Y_0cArs4MQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">james@haydenir.com<\/a><\/u><\/strong><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/67d0d892-49c2-44e7-b453-42626aca6faf\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) &#8212; Delcath Systems, Inc. (Nasdaq:\u00a0DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today that management will participate at these upcoming virtual investor conferences:\u00a0 HC Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021. On demand viewing begins at 7:00 am (ET) Webcast Link:\u00a0https:\/\/journey.ct.events\/view\/7319b60b-6a39-46ed-b3cb-7703cefc889e Virtual 33rd Annual Roth Conference March 15 \u2013 17 1&#215;1 meetings only For more information or to schedule a one-on-one meeting with management, please contact your conference representative or James@HaydenIR.com. About Delcath Systems, Inc. Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational product, HEPZATO KIT (melphalan &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Delcath Systems to Participate at Upcoming Virtual Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-452689","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Delcath Systems to Participate at Upcoming Virtual Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Delcath Systems to Participate at Upcoming Virtual Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) &#8212; Delcath Systems, Inc. (Nasdaq:\u00a0DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today that management will participate at these upcoming virtual investor conferences:\u00a0 HC Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021. On demand viewing begins at 7:00 am (ET) Webcast Link:\u00a0https:\/\/journey.ct.events\/view\/7319b60b-6a39-46ed-b3cb-7703cefc889e Virtual 33rd Annual Roth Conference March 15 \u2013 17 1&#215;1 meetings only For more information or to schedule a one-on-one meeting with management, please contact your conference representative or James@HaydenIR.com. About Delcath Systems, Inc. Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational product, HEPZATO KIT (melphalan &hellip; Continue reading &quot;Delcath Systems to Participate at Upcoming Virtual Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-08T14:03:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Delcath Systems to Participate at Upcoming Virtual Investor Conferences\",\"datePublished\":\"2021-03-08T14:03:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/\",\"name\":\"Delcath Systems to Participate at Upcoming Virtual Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=\",\"datePublished\":\"2021-03-08T14:03:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Delcath Systems to Participate at Upcoming Virtual Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Delcath Systems to Participate at Upcoming Virtual Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"Delcath Systems to Participate at Upcoming Virtual Investor Conferences - Market Newsdesk","og_description":"NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) &#8212; Delcath Systems, Inc. (Nasdaq:\u00a0DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, announced today that management will participate at these upcoming virtual investor conferences:\u00a0 HC Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021. On demand viewing begins at 7:00 am (ET) Webcast Link:\u00a0https:\/\/journey.ct.events\/view\/7319b60b-6a39-46ed-b3cb-7703cefc889e Virtual 33rd Annual Roth Conference March 15 \u2013 17 1&#215;1 meetings only For more information or to schedule a one-on-one meeting with management, please contact your conference representative or James@HaydenIR.com. About Delcath Systems, Inc. Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Our investigational product, HEPZATO KIT (melphalan &hellip; Continue reading \"Delcath Systems to Participate at Upcoming Virtual Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-08T14:03:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Delcath Systems to Participate at Upcoming Virtual Investor Conferences","datePublished":"2021-03-08T14:03:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/","name":"Delcath Systems to Participate at Upcoming Virtual Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=","datePublished":"2021-03-08T14:03:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTY4MCM0MDUxOTEwIzIwMTA1ODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/delcath-systems-to-participate-at-upcoming-virtual-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Delcath Systems to Participate at Upcoming Virtual Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=452689"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452689\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=452689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=452689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=452689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}